A previous communication (1) concerned the application of continuous flow electrophoresis to the fractionation of normal blood preparations and the study of the coagulation proteins in these fractions. It was considered of some interest to apply the same techniques to pathological plasmas obtained from patients suffering from congenital deficiencies of AHF (antihemophilic factor A) and PTC (plasma thromboplastin component, Christmas factor, antihemophilic factor B). In addition, the isolation of an anti-AHF from the plasma of a hemophiliac with an acquired inhibitor is described.
MATERIALS AND METHODS
The methods have been described previously (1, 2) . Plasmas were obtained from six patients, five of whom had suffered from severe and one (C.F.) from moderate hemorrhagic symptoms throughout their lives. Table I shows coagulation studies carried out on these patients on or near the date on which the blood for electrophoresis was obtained. Four patients suffered from AHF deficiency and two from PTC deficiency. All was then transfused with 500 ml. fresh whole blood and tests six days later showed an anti-AHF titer of 1:64. It was at this time that blood for electrophoresis was obtained. 22, a, plus albumin in 23 and albumin in 24 through 27. AHF activity was absent from the whole plasma and all fractions. Each fraction and the mother plasma were incubated with normal AHF and the residual AHF titer measured. No loss of activity was observed; thus no anti-AHF was present. The other coagulation proteins appeared normal in their distribution and concentration. Profibrinolysin and "glass factor" were in the -y area; heparin cofactor in the p area; prothrombin, proconvertin, PTC, antifibrinolysin and antithrombin in the a1 to a2 areas and proaccelerin in the albumin area. Quantities of substrate for measuring Hageman factor and PTA (plasma thromboplastin antecedent) were available for only a few tubes. These activities appeared primarily in the y area.
The two other experiments on hemophilic plasma were very similar. The study on Patient B.T. showed no AHF or anti-AHF in the plasma or any fraction. The study on Patient C.F., a rather mild bleeder, showed some AHF activity (about 1.5 per cent of normal) in the whole plasma and in one fraction in the a1 area.
Hemophilia A zwith anti-AHF. Anti-AHF activity (titer 1:2 to 1:8) was found in four tube fractions. The four tubes (10 through 13) were in the -y-globulin area and separate paper strip electrophoresis also showed these fractions to contain y-globulin. 1924 Profibrinolysin, glass factor, Hageman factor and fibrinogen were found primarily in the -y area; antithrombin, heparin cofactor, antifibrinolysin, proconvertin, prothrombin and AHF in the a2 to a1 areas and proaccelerin in the albumin areas. PTA activity was tested in three tubes and appeared in the y area.
DISCUSSION
Most of the investigators in the field of blood coagulation feel that Hemophilia A and B are disorders due to genetically controlled deficiencies of two distinctly different plasma proteins. A di-T vergent theory (3, 4) explains Hemophilia A as due to the binding of AHF by a circulating inhibitor. If such an AHF-anti-AHF complex exists in hemophilic blood, it is not dissociated by Pro A electrophoresis as neither AHF nor anti-AHF activity could be found in any of the fractions from the plasmas of the severe hemophiliacs. In the study on the mild hemophiliac a trace of AHF was found in the same location (a,.) in which it appears in normal plasma.
The (9) . The close similarity between the distribution of PTA, Hageman factor and "glass factor" in these and in normal plasma is being further explored.
SUM MARY
Continuous flow electrophoretic fractionation was applied to four AHF and two PTC deficient: plasmas. One AHF deficient plasma showed the presence of anti-AHF. Fractions from the three ordinary hemophilic plasmas showed no anti-AHF and no AHF activity with the exception of one fraction from a mild hemophiliac which showed a trace of AHF activity. Fractions from the PTC deficient plasmas showed no PTC or anti-PTC activity. Other coagulation factors appeared normal in concentration and distribution. The anti-AHF activity of the plasma from the patient with an acquired inhibitor was concentrated in the y-globulin area.
